Yongyan Gao

Prof. Yongyan Gao

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2016 in European Journal of Radiology
Verified
Journal Article
Closed access
YGYongyan Gao
Yongyan Gao
PLPing Liang
Ping Liang
XYXiaoling Yu
Xiaoling Yu
JYJie Yu
Jie Yu
ZCZhigang Cheng
Zhigang Cheng
HHHui Huang
Hui Huang

7 October 2021 in Journal of Ultrasound in Medicine
Verified
Journal Article
Closed access
PDF file
HZHaixiang Zhang
Haixiang Zhang
WPWeiping Peng
Weiping Peng
CQChi Qin
Chi Qin
YMYuqian Miao
Yuqian Miao
FZFan Zhou
Fan Zhou
YGYongyan Gao
Yongyan Gao

23 December 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
CQChi Qin
Chi Qin
HJHailong Jin
Hailong Jin
HZHaixiang Zhang
Haixiang Zhang
YZYun Zhang
Yun Zhang
ZGZhaojie Guan
Zhaojie Guan
YGYongyan Gao
Yongyan Gao
The purpose of this study was to evaluate the feasibility of the combination of point-shear wave elastography (p-SWE) and estimated glomerular filtration rate (eGFR) for assessing different stages of interstitial fibrosis and tubular atrophy (IF/TA) in patients with chronic renal allograft dysfunction (CAD). From September 2020 to August 2021, 47 patients who underwent renal biopsy and p-SWE examinations were consecutively enrolled in this study. The areas under the receiver operating characteristic curves (AUCs) were calculated to evaluate overall accuracy and to identify the optimal cutoff values for different IF/TA stages. A total of 43 patients were enrolled in this study. The renal cortical stiffness and eGFR showed a significant difference between IF/TA Grade 0–1 and Grade 2–3 (p < 0.001). Additionally, renal stiffness and eGFR were independent predictors for moderate-to-severe IF/TA (Grade ≥ 2) according to multiple logistic regression analysis. The combination of p-SWE and eGFR, with an optimal cutoff value of −1.63, was superior to eGFR alone in assessing moderate-to-severe interstitial fibrosis (AUC, 0.86 vs. 0.72, p = 0.02) or tubular atrophy (AUC, 0.88 vs. 0.74, p = 0.02). There was no difference between p-SWE and eGFR in assessing moderate-to-severe IF/TA (AUC, 0.85 vs. 0.79, p = 0.61). Therefore, combining p-SWE and eGFR is worthy of clinical popularization and application.